Gene · 51441
Papers3,768
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,768
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single residues within the YTHDF intrinsically disordered region control m 6 A-dependent mRNA decay. | bioRxiv | 2026 | 42818126 | PubTator, text mining | PubMed |
| From translation milestones to clinical breakthroughs: Decision-making hubs and translational strategies for RNA-binding proteins in the immunotherapy of haematological malignancies. | Crit Rev Oncol Hematol | 2026 | 42805357 | PubTator, text mining | PubMed |
| Epitranscriptomic regulation of Notch signaling. | Cell Signal | 2026 | 42800623 | PubTator, text mining | PubMed |
| FTO-Driven m6A Demethylation of TNC Promotes Epithelial-Mesenchymal Transition and Gastric Cancer Metastasis. | Biomedicines | 2026 | 42792700 | PubTator, text mining | PubMed |
| Zearalenone suppresses pituitary follicle-stimulating hormone synthesis via ALKBH5-YTHDF2-SMAD4 axis. | J Hazard Mater | 2026 | 42772075 | PubTator, text mining | PubMed |
| Destabilization of hsa_circ_0015508 by YTHDF2 Enhances miR-496-Mediated FOXN3 Suppression to Drive Nasopharyngeal Carcinoma Progression. | Oncol Res | 2026 | 42769473 | PubTator, text mining | PubMed |
| Targeting the SETD2-FTO-KIT pathway as a pharmacological strategy for TKI-refractory GIST. | Acta Pharm Sin B | 2026 | 42764990 | PubTator, text mining | PubMed |
| Allosteric modulation of YTHDFs by ellagic acid suppresses triple-negative breast cancer via non-canonical activation of the HIF-1α pathway. | Cell Rep Med | 2026 | 42748913 | PubTator, text mining | PubMed |
| circNfix attenuates acute kidney injury by driving m6A-dependent degradation of YTHDF2 to stabilize DAPK2 mRNA. | Clin Sci (Lond) | 2026 | 42742123 | PubTator, text mining | PubMed |
| METTL14 alleviates pyroptosis of placental trophoblasts in gestational diabetes mellitus through the lncRNA MEG8/WNT7A axis via m6A modification. | Funct Integr Genomics | 2026 | 42726311 | PubTator, text mining | PubMed |
| Development of m6A-related prognostic models for survival in lung squamous cell carcinoma with different PD-L1 expression levels. | Transl Cancer Res | 2026 | 42724890 | PubTator, text mining | PubMed |
| FTH1 mRNA-Protein Discordance in Cardiac Ferroptosis: Multilayer Posttranscriptional and Degradative Control. | Cardiovasc Ther | 2026 | 42723477 | PubTator, text mining | PubMed |
| LAMTOR5 drives glioblastoma progression via activation of the HOXC9/YTHDF2 positive feedback loop. | J Biol Chem | 2026 | 42710662 | PubTator, text mining | PubMed |
| Correction: METTL3 suppresses pyroptosis in obstructive sleep apnea-associated hypertension via YTHDF2-mediated SOX4 mRNA degradation. | J Physiol Biochem | 2026 | 42704560 | PubTator, text mining | PubMed |
| Role and prognostic value of N6-methyladenosine RNA modification regulators in glycolytic reprogramming during sepsis. | J Intensive Care | 2026 | 42675521 | PubTator, text mining | PubMed |
| The m⁶A reader YTHDF2 regulates mRNA transport and axon outgrowth in developing neurons. | Nat Commun | 2026 | 42669734 | PubTator, text mining | PubMed |
| METTL18-catalyzed histidine methylation of YTHDF2 promotes mRNA stability. | Sci China Life Sci | 2026 | 42667539 | PubTator, text mining | PubMed |
| METTL3-Mediated m6A Modification of ACTR2 Promotes Trophoblast Cell Growth, Migration and Invasion in Unexplained Recurrent Spontaneous Abortion. | Cell Biochem Biophys | 2026 | 42631821 | PubTator, text mining | PubMed |
| ALKBH3 inhibition normalizes neovessels by reprogramming endothelial fate in diabetic microvasculopathy. | Proc Natl Acad Sci U S A | 2026 | 42627826 | PubTator, text mining | PubMed |
| Integrative single-cell transcriptomic and epitranscriptomic analysis of the RBM15-m6A-IL10 regulatory axis in psoriatic keratinocytes. | Front Cell Dev Biol | 2026 | 42614367 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51441/papers